ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: DETAILED SAFETY ANALYSIS FROM THE RANDOMIZED PHASE 3 HERO STUDY

被引：0
|
作者：
Mehlhaff, Bryan
Shore, Neal D.
George, Daniel J.
Cookson, Michael S.
Saltzstein, Daniel R.
Tutrone, Ronald
Bailen, James L.
Brown, Bruce
Langenberg, Andria G. M.
Fallick, Mark
Lu, Sophia
Hanson, Sarah
Tombal, Bertrand
Saad, Fred
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP27-16
引用
收藏
页码：E456 / E456
页数：1
相关论文
共 50 条
  • [41] Relugolix, A Novel Oral GnRH Receptor Antagonist, versus Leuprolide Depot for Prostate Cancer: The HERO Phase 3 Trial
    Spratt, D. E.
    Shore, N.
    Bossi, A.
    van Veenhuyzen, D.
    Selby, B.
    Kang, V.
    Dearnaley, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S18 - S19
  • [42] Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
    Mason, Malcolm D.
    Parulekar, Wendy R.
    Sydes, Matthew R.
    Brundage, Michael
    Kirkbride, Peter
    Gospodarowicz, Mary
    Cowan, Richard
    Kostashuk, Edmund C.
    Anderson, John
    Swanson, Gregory
    Parmar, Mahesh K. B.
    Hayter, Charles
    Jovic, Gordana
    Hiltz, Andrea
    Hetherington, John
    Sathya, Jinka
    Barber, James B. P.
    McKenzie, Michael
    El-Sharkawi, Salah
    Souhami, Luis
    Hardman, P. D. John
    Chen, Bingshu E.
    Warde, Padraig
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2143 - U170
  • [43] Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer
    Shore, Neal D.
    Sutton, Jennifer
    FUTURE ONCOLOGY, 2022, 18 (21) : 2575 - 2584
  • [44] Sustained castration to < 20 ng/dl for relugolix vs. leuprolide in men with advanced prostate cancer: Results from the phase 3 HERO study
    Tombal, B.
    Shore, N. D.
    George, D. J.
    Cookson, M. S.
    Saltzstein, D. R.
    Mehlhaff, B.
    Tutrone, R.
    Bailen, J. L.
    Brown, B.
    Lu, S.
    Schulmann, T.
    Hanson, S.
    Saad, F.
    EUROPEAN UROLOGY, 2022, 81 : S771 - S772
  • [45] A pilot study of intermittent androgen deprivation in advanced prostate cancer
    Horwich, A
    Huddart, RA
    Gadd, J
    Boyd, PJ
    Hetherington, JW
    Whelan, P
    Dearnaley, DP
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (01): : 96 - 99
  • [46] Androgen deprivation therapy for advanced prostate cancer in Sarawak General Hospital
    Chan, S. H.
    Rufaey, A.
    Lim, M. S.
    Toh, C. C.
    Teh, G. C.
    Lei, C. M.
    BJU INTERNATIONAL, 2015, 116 : 25 - 26
  • [47] Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer
    Calleary, John G.
    UROLOGY, 2017, 103 : 171 - 172
  • [48] Androgen Deprivation Therapy for Advanced Prostate Cancer: Can Evolution Be Accelerated?
    Mohler, James L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (06): : 701 - 703
  • [49] Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials
    Loblaw, D. A.
    Bassett, J.
    D'Este, C.
    Pond, G.
    Cheung, P.
    Frydenberg, M.
    King, M. T.
    Lukka, H.
    Malone, S.
    Millar, J. L.
    Milne, R. L.
    Pickles, T.
    Smith, R.
    Stockler, M. R.
    Turner, S.
    Tai, K. H.
    Woo, H.
    Duchesne, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S148 - S148
  • [50] The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer
    Reiss, Allison B.
    Vasalani, Samantha
    Albert, Jacqueline
    Drewes, Wendy
    Li, Kathleen
    Srivastava, Ankita
    De Leon, Joshua
    Katz, Aaron E.
    MEDICINA-LITHUANIA, 2024, 60 (11):
12345